ovarian cancer is important
because it is the leading close off gynaecology kind of cancer
deaths and the fifth leading cause of cancer related deaths among women
most women present we've advanced disease mainly because the non specific nature of symptoms
leads to diagnostic delays
recent data have shown a fall in over and constant mortality rate in the u
k
but rate are still higher when compared to other european countries in the united states
of america
the outlook for women we've ovarian cancer remains pull with an overall five here survivor
right off
less than fifty percent large epidemiological studies have reported
poor survival rates for vowel and consonant the uk when compared to other european countries
australia and canada
this is in spite of the uk having a lead role in both
a research and training conducting many of the major trial was invited cancer research and
being the first your first european country to implement
full model kind ecological and quality training in addition surgeons in the u k that's
a on average loehr surgical cited reduction rates in places with advanced ovarian cancer the
aim of this review this to present
an overview of clinical epidemiology for the filler ovarian cancer in the united kingdom
with an emphasis on incidence mortality and survival rate trends over time trends by aids
international comparisons and national and regional variation in survivor instance and mortality are presented in
the context of a major reorganisation of cancer services
that took place in the u k over ten years ago centralization of cancer services
has meant that women with ovarian cancer now receive treatment is tested least cancer centres